Orin
IFFNYSE·Chemicals - Specialty

International Flavors & Fragrances Inc. IFF

Market cap $21.9BP/E 78.8× trailingGross margin 37.5%Reports Tue 3 Nov, after the close
$85.67
−0.18 (−0.21%)live 11:30 ET
52-wk $59.14 – $89.32
Watch
Orin's take
0.62conviction · moderate
Refreshed 20 Aug · take v7. A new filing or a print queues the next refresh.

IFF is a mixed transformation story: debt has been cut from $12.2B (2021) to $6.65B (2025) and gross margin expanded to 36.2%, but FY2025 still produced a $361M net loss on 5.2% revenue decline, with FCF halving to $256M. The stock trades at 76.4x trailing earnings — a 305% premium to the peer median of 18.9x — which prices in a turnaround that Q2 2026's $0.82 EPS (versus $1.14 consensus) did not confirm.

With the pending Food Ingredients divestiture and a new buyback as potential catalysts, plus a large director purchase at $74.28 in June 2026, the setup is balanced enough to wait for evidence rather than chase or dump at $83.33.

What could go wrong

  • Valuation compression. At 76.4x P/E versus a peer median of 18.9x, any further earnings miss could trigger a sharp derating; the Q2 2026 EPS of $0.82 already missed the $1.14 consensus.
  • Revenue erosion. FY2025 revenue fell 5.2% YoY to $10.89B from $11.48B, and if the Food Ingredients sale shrinks the top line further without offsetting growth, the deleveraging story loses momentum.
  • Insider selling acceleration. Multiple executives sold in August 2026 — the CFO, CAO, and President of Scent all liquidated shares at $83–$86 — which could signal lack of confidence in near-term execution.
  • FCF deterioration. Free cash flow fell from $602M in 2024 to $256M in 2025 while capex rose to $594M, limiting financial flexibility for buybacks and debt reduction simultaneously.

What would change my mind

Food Ingredients sale closing. Announcement of closing price and use of proceeds for the Food Ingredients divestiture, showing debt paydown or buyback accelerationbullish
Q3 2026 EPS re-acceleration. Q3 2026 adjusted EPS meets or exceeds consensus with organic volume growth, reversing the Q2 miss patternbullish
Margin contraction. Gross margin falls below 35% or operating margin contracts below 7% in a reported quarter, signaling the portfolio simplification is not deliveringbearish
Guidance cut. Management lowers full-year 2026 revenue or EPS guidance at the Barclays conference or next earnings, confirming the Q2 miss was not isolatedbearish

Where this comes from: FMP annual fundamentals · FMP annual fundamentals + derived_metrics · FMP annual fundamentals · peer_relative composite. Orin's read on IFF; not advice.

Twelve months actual closes to 2026-09-24 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Vanguard Capital Management$1.3B0.0% of fund
State Street$982.4M0.0% of fund
Vanguard Portfolio Management$919.6M0.0% of fund
Invesco$744.9M0.1% of fund
Geode Capital Management$537.6M0.0% of fund
Icahn Carl C$338.7M4.1% of fund

78 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 210 Form 4 filings, net $34.1M. Of the 50 on hand, 2 were open-market purchases and 3 sales— the rest are grants, option exercises and tax withholding.

Ask Orin about IFF

its filings · its transcripts · its numbers

Orin answers questions about IFF from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days →

Where it trades

vs its own 5y · Basic Materials
MetricNowOwn medianSector
P/E78.8×—29.8×
EV/EBITDA18.6×——
P/S2.20×1.88×—
P/B1.6×1.5×—

Its P/E sits 60th percentile of its own last 5 years (+0.68σ from its own mean).

What the price assumes

27.7%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $0.3B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

34 firms · 2026-09-24
Consensus target

$95

$91 – $100 · +11% against today's price

How they rate it
  • 25 buy or overweight
  • 8 hold
  • 1 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 22.3× of 5 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
IFFInternational Flavors & Fragrances Inc.$22B78.8×18.6×37.5%2.9%2%
ALBAlbemarle Corporation$13B225.5×10.7×23.9%3.8%2%
DDDuPont de Nemours, Inc.$18B283.2×14.3×34.4%0.7%0%
DOWDow Inc.$21B—16.3×9.8%-2.9%-7%
LYBLyondellBasell Industries N.V.$19B—16.4×13.2%-1.1%-3%
PPGPPG Industries, Inc.$24B15.1×10.6×40.1%9.6%19%
RPMRPM International Inc.$13B19.0×11.4×41.4%8.4%21%
RSReliance Steel & Aluminum Co.$20B22.3×14.1×26.9%5.7%12%
WLKWestlake Corporation$9B——4.7%-10.9%-14%

The median is of the 5 peers listed above and nothing else — check it against the column. This company trades 253.2% above it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY14 19.9×FY24 89.0×

What its sector has traded at

Basic Materials
FY14 23.8×FY26 28.6×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Discounted cash flow

not recomputed since
ModelFair valueAgainstComputed
Standard DCF$3$75.70 · −96%2026-06-10
Levered DCF$9$75.70 · −89%2026-06-10

The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.

Every estimate on one scale

price $85.67
52-week range$59 – $89
Analyst targets$91 – $100
Standard DCF$3 as of 2026-06-10, when it was $75.70
Levered DCF$9 as of 2026-06-10, when it was $75.70
At own 5y-median P/E (-8×)$-9
At 5y P/E range (-48–137×)$-52 – $149
At sector P/E (30×)$32

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.